- Home
- ILAG vs PSTV Comparison
ILAG vs PSTV Comparison
Compare ILAG & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILAG | PSTV |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 61.1M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ILAG | PSTV |
|---|---|---|
| Price | $0.47 | $0.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 20.8K | ★ 6.0M |
| Earning Date | 04-28-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,506,551.00 | $5,258,000.00 |
| Revenue This Year | N/A | $28.21 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.50 | N/A |
| 52 Week Low | $0.34 | $0.16 |
| 52 Week High | $0.98 | $2.31 |
Technical Indicators
Market Signals| Indicator | ILAG | PSTV |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 45.80 |
| Support Level | $0.42 | $0.61 |
| Resistance Level | $0.53 | $0.76 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 34.23 | 12.37 |
Price Performance
Historical ComparisonAbout ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).